AR and Familial prostate cancer: With this oncogenic activation, it promotes cancer stemness, activated stroma and altered microenvironment, EMT and metastasis, reciprocal crosstalk with androgen receptor (AR) and therapy-resistance in different stages of prostate cancer progression [19–23].